Review



stimulation with il33  (Sino Biological)


Bioz Verified Symbol Sino Biological is a verified supplier
Bioz Manufacturer Symbol Sino Biological manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Sino Biological stimulation with il33
    (A) Crystal structure of IL1RAP (PDB: 4DEP), with IL1 (olive), IL-1RI (grey) and c2d2 loop (blue) interfaces colored. (B) Crystal structure of IL1RAP (PDB: 5VI4), with <t>IL33</t> (cyan), IL-33R (pink) and c2d2 loop (green) interfaces colored. (C) Crystal structure of IL1RAP (PDB: 3O4O), with IL1 (dark goldenrod), IL-1R2 (deep pink) and c2d2 loop (red) interfaces colored. (D) Schematic diagram of antibody discovery and screening workflow. (E) ELISA binding assessment of the parental antibody to full-length IL1RAP and its individual domains.
    Stimulation With Il33, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/stimulation+with+il33/bio_rxiv__64898__2026__02__13__705739-186-15-18?v=Sino+Biological
    Average 94 stars, based on 12 article reviews
    stimulation with il33 - by Bioz Stars, 2026-07
    94/100 stars

    Images

    1) Product Images from "Anti-IL1RAP Antibodies for Pan-Inhibition of IL-1 Family Cytokine Signaling in Inflammatory Diseases and Oncology"

    Article Title: Anti-IL1RAP Antibodies for Pan-Inhibition of IL-1 Family Cytokine Signaling in Inflammatory Diseases and Oncology

    Journal: bioRxiv

    doi: 10.64898/2026.02.13.705739

    (A) Crystal structure of IL1RAP (PDB: 4DEP), with IL1 (olive), IL-1RI (grey) and c2d2 loop (blue) interfaces colored. (B) Crystal structure of IL1RAP (PDB: 5VI4), with IL33 (cyan), IL-33R (pink) and c2d2 loop (green) interfaces colored. (C) Crystal structure of IL1RAP (PDB: 3O4O), with IL1 (dark goldenrod), IL-1R2 (deep pink) and c2d2 loop (red) interfaces colored. (D) Schematic diagram of antibody discovery and screening workflow. (E) ELISA binding assessment of the parental antibody to full-length IL1RAP and its individual domains.
    Figure Legend Snippet: (A) Crystal structure of IL1RAP (PDB: 4DEP), with IL1 (olive), IL-1RI (grey) and c2d2 loop (blue) interfaces colored. (B) Crystal structure of IL1RAP (PDB: 5VI4), with IL33 (cyan), IL-33R (pink) and c2d2 loop (green) interfaces colored. (C) Crystal structure of IL1RAP (PDB: 3O4O), with IL1 (dark goldenrod), IL-1R2 (deep pink) and c2d2 loop (red) interfaces colored. (D) Schematic diagram of antibody discovery and screening workflow. (E) ELISA binding assessment of the parental antibody to full-length IL1RAP and its individual domains.

    Techniques Used: Enzyme-linked Immunosorbent Assay, Binding Assay

    (A-B) Inhibition of IL1α (A) and IL1β (B) induced signaling by indicated antibodies in HEK-Blue IL-1 reporter cells. (C) Inhibition of IL33 induced signaling by indicated antibodies in HUVEC cells. (D) Inhibition of IL1α, IL1β, and IL33 induced signaling by indicated antibodies in HUVEC cells. (E-G) Inhibition of IL36α (E), IL36β (F) and IL36γ (G) induced signaling by indicated antibodies in A431 cells. (H) Inhibition of IL1α, IL1β, IL36α, IL36β, and IL36γ induced signaling by indicated antibodies in A431 cells.
    Figure Legend Snippet: (A-B) Inhibition of IL1α (A) and IL1β (B) induced signaling by indicated antibodies in HEK-Blue IL-1 reporter cells. (C) Inhibition of IL33 induced signaling by indicated antibodies in HUVEC cells. (D) Inhibition of IL1α, IL1β, and IL33 induced signaling by indicated antibodies in HUVEC cells. (E-G) Inhibition of IL36α (E), IL36β (F) and IL36γ (G) induced signaling by indicated antibodies in A431 cells. (H) Inhibition of IL1α, IL1β, IL36α, IL36β, and IL36γ induced signaling by indicated antibodies in A431 cells.

    Techniques Used: Inhibition

    (A) Cryo-EM map of the complex that contains DXP-006 (purple and pink), IL1RAP (cyan; domain 2 and domain 3) and density map (grey), c2d2 loop (blue density map). (B) Interfaces between DXP-006 and IL1RAP. (C) Crystal structure of IL1RAP with the DXP-006 Interface (cyan) and CAN10 interface (blue). (D) Crystal structure of IL1RAP domain 2 and domain 3 (PDB:4DEP), colored with IL-1 (yellow), IL33 (orange), IL-36 (green) and DXP-006 (cyan) interface.
    Figure Legend Snippet: (A) Cryo-EM map of the complex that contains DXP-006 (purple and pink), IL1RAP (cyan; domain 2 and domain 3) and density map (grey), c2d2 loop (blue density map). (B) Interfaces between DXP-006 and IL1RAP. (C) Crystal structure of IL1RAP with the DXP-006 Interface (cyan) and CAN10 interface (blue). (D) Crystal structure of IL1RAP domain 2 and domain 3 (PDB:4DEP), colored with IL-1 (yellow), IL33 (orange), IL-36 (green) and DXP-006 (cyan) interface.

    Techniques Used: Cryo-EM Sample Prep

    (A-B) Inhibition of IL1α (A) and IL1β (B) induced signaling by indicated antibodies in HEK-Blue IL-1 reporter cells. (C) Inhibition of IL33 induced signaling by indicated antibodies in HUVEC cells. (D-F) Inhibition of IL36α (D), IL36β (E) and IL36γ (F) induced signaling by indicated antibodies in A431 cells.
    Figure Legend Snippet: (A-B) Inhibition of IL1α (A) and IL1β (B) induced signaling by indicated antibodies in HEK-Blue IL-1 reporter cells. (C) Inhibition of IL33 induced signaling by indicated antibodies in HUVEC cells. (D-F) Inhibition of IL36α (D), IL36β (E) and IL36γ (F) induced signaling by indicated antibodies in A431 cells.

    Techniques Used: Inhibition



    Similar Products

    stimulation with il33  (Sino Biological)
    94
    Sino Biological stimulation with il33
    (A) Crystal structure of IL1RAP (PDB: 4DEP), with IL1 (olive), IL-1RI (grey) and c2d2 loop (blue) interfaces colored. (B) Crystal structure of IL1RAP (PDB: 5VI4), with <t>IL33</t> (cyan), IL-33R (pink) and c2d2 loop (green) interfaces colored. (C) Crystal structure of IL1RAP (PDB: 3O4O), with IL1 (dark goldenrod), IL-1R2 (deep pink) and c2d2 loop (red) interfaces colored. (D) Schematic diagram of antibody discovery and screening workflow. (E) ELISA binding assessment of the parental antibody to full-length IL1RAP and its individual domains.
    Stimulation With Il33, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/stimulation+with+il33/bio_rxiv__64898__2026__02__13__705739-186-15-18?v=Sino+Biological
    Average 94 stars, based on 1 article reviews
    stimulation with il33 - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    il 33 stimulation group  (Sino Biological)
    94
    Sino Biological il 33 stimulation group
    (A) Crystal structure of IL1RAP (PDB: 4DEP), with IL1 (olive), IL-1RI (grey) and c2d2 loop (blue) interfaces colored. (B) Crystal structure of IL1RAP (PDB: 5VI4), with <t>IL33</t> (cyan), IL-33R (pink) and c2d2 loop (green) interfaces colored. (C) Crystal structure of IL1RAP (PDB: 3O4O), with IL1 (dark goldenrod), IL-1R2 (deep pink) and c2d2 loop (red) interfaces colored. (D) Schematic diagram of antibody discovery and screening workflow. (E) ELISA binding assessment of the parental antibody to full-length IL1RAP and its individual domains.
    Il 33 Stimulation Group, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/stimulation+with+il33/pm34354706-74-8-14?v=Sino+Biological
    Average 94 stars, based on 1 article reviews
    il 33 stimulation group - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Crystal structure of IL1RAP (PDB: 4DEP), with IL1 (olive), IL-1RI (grey) and c2d2 loop (blue) interfaces colored. (B) Crystal structure of IL1RAP (PDB: 5VI4), with IL33 (cyan), IL-33R (pink) and c2d2 loop (green) interfaces colored. (C) Crystal structure of IL1RAP (PDB: 3O4O), with IL1 (dark goldenrod), IL-1R2 (deep pink) and c2d2 loop (red) interfaces colored. (D) Schematic diagram of antibody discovery and screening workflow. (E) ELISA binding assessment of the parental antibody to full-length IL1RAP and its individual domains.

    Journal: bioRxiv

    Article Title: Anti-IL1RAP Antibodies for Pan-Inhibition of IL-1 Family Cytokine Signaling in Inflammatory Diseases and Oncology

    doi: 10.64898/2026.02.13.705739

    Figure Lengend Snippet: (A) Crystal structure of IL1RAP (PDB: 4DEP), with IL1 (olive), IL-1RI (grey) and c2d2 loop (blue) interfaces colored. (B) Crystal structure of IL1RAP (PDB: 5VI4), with IL33 (cyan), IL-33R (pink) and c2d2 loop (green) interfaces colored. (C) Crystal structure of IL1RAP (PDB: 3O4O), with IL1 (dark goldenrod), IL-1R2 (deep pink) and c2d2 loop (red) interfaces colored. (D) Schematic diagram of antibody discovery and screening workflow. (E) ELISA binding assessment of the parental antibody to full-length IL1RAP and its individual domains.

    Article Snippet: Cells were treated with escalating concentrations of DXP-006, DXP-106, or antagonists as indicated, followed by stimulation with IL33 (Sinobiological, 10368-HNAE) or IL1α+IL1β+IL33 at their respective pre-determined EC 80 .

    Techniques: Enzyme-linked Immunosorbent Assay, Binding Assay

    (A-B) Inhibition of IL1α (A) and IL1β (B) induced signaling by indicated antibodies in HEK-Blue IL-1 reporter cells. (C) Inhibition of IL33 induced signaling by indicated antibodies in HUVEC cells. (D) Inhibition of IL1α, IL1β, and IL33 induced signaling by indicated antibodies in HUVEC cells. (E-G) Inhibition of IL36α (E), IL36β (F) and IL36γ (G) induced signaling by indicated antibodies in A431 cells. (H) Inhibition of IL1α, IL1β, IL36α, IL36β, and IL36γ induced signaling by indicated antibodies in A431 cells.

    Journal: bioRxiv

    Article Title: Anti-IL1RAP Antibodies for Pan-Inhibition of IL-1 Family Cytokine Signaling in Inflammatory Diseases and Oncology

    doi: 10.64898/2026.02.13.705739

    Figure Lengend Snippet: (A-B) Inhibition of IL1α (A) and IL1β (B) induced signaling by indicated antibodies in HEK-Blue IL-1 reporter cells. (C) Inhibition of IL33 induced signaling by indicated antibodies in HUVEC cells. (D) Inhibition of IL1α, IL1β, and IL33 induced signaling by indicated antibodies in HUVEC cells. (E-G) Inhibition of IL36α (E), IL36β (F) and IL36γ (G) induced signaling by indicated antibodies in A431 cells. (H) Inhibition of IL1α, IL1β, IL36α, IL36β, and IL36γ induced signaling by indicated antibodies in A431 cells.

    Article Snippet: Cells were treated with escalating concentrations of DXP-006, DXP-106, or antagonists as indicated, followed by stimulation with IL33 (Sinobiological, 10368-HNAE) or IL1α+IL1β+IL33 at their respective pre-determined EC 80 .

    Techniques: Inhibition

    (A) Cryo-EM map of the complex that contains DXP-006 (purple and pink), IL1RAP (cyan; domain 2 and domain 3) and density map (grey), c2d2 loop (blue density map). (B) Interfaces between DXP-006 and IL1RAP. (C) Crystal structure of IL1RAP with the DXP-006 Interface (cyan) and CAN10 interface (blue). (D) Crystal structure of IL1RAP domain 2 and domain 3 (PDB:4DEP), colored with IL-1 (yellow), IL33 (orange), IL-36 (green) and DXP-006 (cyan) interface.

    Journal: bioRxiv

    Article Title: Anti-IL1RAP Antibodies for Pan-Inhibition of IL-1 Family Cytokine Signaling in Inflammatory Diseases and Oncology

    doi: 10.64898/2026.02.13.705739

    Figure Lengend Snippet: (A) Cryo-EM map of the complex that contains DXP-006 (purple and pink), IL1RAP (cyan; domain 2 and domain 3) and density map (grey), c2d2 loop (blue density map). (B) Interfaces between DXP-006 and IL1RAP. (C) Crystal structure of IL1RAP with the DXP-006 Interface (cyan) and CAN10 interface (blue). (D) Crystal structure of IL1RAP domain 2 and domain 3 (PDB:4DEP), colored with IL-1 (yellow), IL33 (orange), IL-36 (green) and DXP-006 (cyan) interface.

    Article Snippet: Cells were treated with escalating concentrations of DXP-006, DXP-106, or antagonists as indicated, followed by stimulation with IL33 (Sinobiological, 10368-HNAE) or IL1α+IL1β+IL33 at their respective pre-determined EC 80 .

    Techniques: Cryo-EM Sample Prep

    (A-B) Inhibition of IL1α (A) and IL1β (B) induced signaling by indicated antibodies in HEK-Blue IL-1 reporter cells. (C) Inhibition of IL33 induced signaling by indicated antibodies in HUVEC cells. (D-F) Inhibition of IL36α (D), IL36β (E) and IL36γ (F) induced signaling by indicated antibodies in A431 cells.

    Journal: bioRxiv

    Article Title: Anti-IL1RAP Antibodies for Pan-Inhibition of IL-1 Family Cytokine Signaling in Inflammatory Diseases and Oncology

    doi: 10.64898/2026.02.13.705739

    Figure Lengend Snippet: (A-B) Inhibition of IL1α (A) and IL1β (B) induced signaling by indicated antibodies in HEK-Blue IL-1 reporter cells. (C) Inhibition of IL33 induced signaling by indicated antibodies in HUVEC cells. (D-F) Inhibition of IL36α (D), IL36β (E) and IL36γ (F) induced signaling by indicated antibodies in A431 cells.

    Article Snippet: Cells were treated with escalating concentrations of DXP-006, DXP-106, or antagonists as indicated, followed by stimulation with IL33 (Sinobiological, 10368-HNAE) or IL1α+IL1β+IL33 at their respective pre-determined EC 80 .

    Techniques: Inhibition